​European Journal of Oncology Pharmacy – the official journal of the European Society of Oncology Pharmacy - is a new peer-reviewed, pharmaceutical journal in the field of cancer treatment. It will focus on the role of pharmacists in the prevention and treatment of cancers under its scope. This includes basic and applied researches on the synthesis or extraction, compounding, analysis, stability, pharmacology, side-effects and clinical use of anticancer drugs and adjuvants therapies such as antiemetic, analgesic or complementary medicines.

The Editor-in-Chief of the journal is Professor Alain Astier, University Hospital Henri Mondor, Paris 12 University. As Prof Astier said: "I am convinced that EJOP should be the journal of reference for pharmacists working in the field of oncology. However, we believe that EJOP could also be an excellent multidisciplinary publication platform for those interested in all the aspects of the pharmacological approach to cancer treatment. Our editorial board is constituted of recognized worldwide specialists from all the major fields of oncology pharmacy, thus guaranteeing the highest quality of the published papers."

Authors are encouraged to share their ideas and valuable research outcomes through EJOP and provide the global readers updated and most important information in the mode of original articles, review articles, case reports, short communications, etc. The journal will be interested in featuring articles discussing the multi- professional approaches of patient care.

The journal is open for the submission and peer review of manuscripts. All manuscripts must be submitted online at: www.editorialmanager.com/ejop.